QR-koodi

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study

Background: The effective development of COVID-19 vaccination has mitigated its harm. Using two laboratory methods, we investigated the efficacy of the BNT162b2 mRNA and BBIBP-CorV COVID-19 vaccines on seroconversion rates in cancer patients undergoing active cancer treatment. Methods: SARS-CoV-2 va...

Täydet tiedot

Tallennettuna:
Päätekijät: Lina Souan, Hikmat Abdel-Razeq, Sura Nashwan, Sara Al Badr, Kamal Alrabi, Maher A. Sughayer
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2023-10-01
Sarja:Vaccines
Aiheet:
COVID-19
Pfizer BioNTech (BNT162b2)
mRNA vaccine
BBIBP-CorV-virus
inactivated vaccine
IgG antibody titer
Linkit:https://www.mdpi.com/2076-393X/11/11/1659
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia